


Ask a doctor about a prescription for RUPATADINE AUROVITAS 10 mg TABLETS
Package Leaflet: Information for the User
Rupatadina Aurovitas 10 mg Tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Rupatadina is an antihistamine.
Rupatadina is indicated for the relief of symptoms of allergic rhinitis such as sneezing, runny nose, itchy eyes and nose.
Rupatadina is also indicated for the relief of symptoms associated with urticaria (allergic skin rash) such as itching and skin rash (redness and swelling of the skin).
Do not takeRupatadina Aurovitas
Warnings and precautions
Consult your doctor or pharmacist before taking Rupatadina Aurovitas.
Children
This medicine should not be used in children under 12 years of age.
Other medicines andRupatadina Aurovitas
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
TakingRupatadina Aurovitaswith food, drinks and alcohol
Do not takerupatadinain combination with grapefruit juice because it may increase the level of rupatadina in your body.
Rupatadina, at the recommended dose of 10 mg, does not increase the drowsiness produced by alcohol.
Pregnancy, breast-feeding and fertility
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Driving and using machines
It is unlikely that the recommended dose of rupatadina will have an effect on your ability to drive or use machines. However, when you first start taking rupatadina, be careful to see how it affects you before driving or using machines.
Rupatadina Aurovitascontains lactose
This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
Follow exactly the administration instructions of this medicine given by your doctor. If you are unsure, consult your doctor or pharmacist again.
Rupatadina is administered in adolescents (from 12 years of age) and adults.
The recommended dose is one tablet (10 mg of rupatadina) once a day, with or without food. Swallow the tablet with a sufficient amount of liquid (e.g., a glass of water).
Your doctor will indicate the duration of your treatment with rupatadina.
If you take moreRupatadina Aurovitasthan you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone: 91 562 04 20, indicating the medicine and the amount taken.
If you forget to takeRupatadina Aurovitas
Take your dose as soon as possible and continue with your tablets at the usual times. Do not take a double dose to make up for forgotten doses.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Common side effects(may affect up to 1 in 10 people):
Drowsiness, headache, dizziness, dry mouth, feeling of weakness and fatigue.
Uncommon side effects(may affect up to 1 in 100 people):
Increased appetite, irritability, difficulty concentrating, nosebleeds, dry nose, sore throat, cough, dry throat, rhinitis, nausea, abdominal pain, diarrhea, indigestion, vomiting, constipation, skin rash, back pain, joint pain, muscle pain, thirst, malaise, fever, abnormal liver function tests and weight gain.
Rare side effects(may affect up to 1 in 1,000 people):
Palpitations, increased heart rate and allergic reactions (itching, urticaria and swelling of the face, lips, tongue or throat).
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist, even if they are not listed in this leaflet. You can also report side effects directly through the Spanish Medicines Monitoring System: www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date is the last day of the month stated.
Store the blister in the outer packaging to protect it from light.
Medicines should not be disposed of via wastewater or household waste. Return any unused medicine to your pharmacist. If you are unsure, ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Composition ofRupatadina Aurovitas
Appearance and packaging
Uncoated salmon-colored tablets, round, 6.35 mm ± 0.1 mm, biconvex, flat on both sides.
Package sizes:10, 20 and 30 tablets.
Not all pack sizes may be marketed.
Marketing authorisation holder and manufacturer
Marketing authorisation holder
Aurovitas Spain, S.A.U.
Avda. de Burgos, 16-D
28036 Madrid
Spain
Manufacturer
APL Swift Services (Malta) Limited
HF26, Hal Far Industrial Estate, Hal Far
Birzebbugia, BBG 3000
Malta
O
Generis Farmacêutica, S.A.
Rua João de Deus, 19
2700-487 Amadora
Portugal
This medicine is authorised in the Member States of the European Economic Area under the following names:
Spain: | Rupatadina Aurovitas 10 mg tablets EFG |
Italy: | Rupatadina Aurobindo |
Poland: | Aurofin |
Portugal: | Rupatadina Aurobindo |
Date of last revision of this leaflet: December 2022
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/).
The average price of RUPATADINE AUROVITAS 10 mg TABLETS in November, 2025 is around 6.98 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for RUPATADINE AUROVITAS 10 mg TABLETS – subject to medical assessment and local rules.